Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-05-29 @ 3:38 AM
Study NCT ID:
NCT03902769
Status:
UNKNOWN
Last Update Posted:
2019-04-08
First Post:
2019-04-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Length of Remission With Intensive Chemotherapy in Rapidly Responding AML Patients.
Sponsor:
Rambam Health Care Campus
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
RMB-250-18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None